Institution
Markey Cancer Center
Also known as: MCC
- 253running trials
- 82closed trials
- 3,960publications (OpenAlex)
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation
Recruiting
Recruiting
Recruiting
Recruiting
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Recruiting
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Recruiting
Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Active, not recruiting
Recruiting
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Showing 50 of 253.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers24 recruiting
- Lung cancer16 recruiting
- Acute myeloid leukaemia11 recruiting
- Head and neck cancer8 recruiting
- Acute lymphoblastic leukaemia6 recruiting
- Bladder cancer6 recruiting
- Pancreatic cancer6 recruiting
- Ovarian cancer5 recruiting
- Prostate cancer5 recruiting
- Colorectal cancer4 recruiting
- Kidney cancer4 recruiting
- Neuroendocrine tumours4 recruiting
- Cervical cancer3 recruiting
- Endometrial cancer3 recruiting
- Melanoma3 recruiting
- Myelodysplastic syndromes3 recruiting
- Myeloproliferative neoplasms3 recruiting
- Sarcoma3 recruiting
- Down syndrome2 recruiting
- Follicular lymphoma2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Glioblastoma2 recruiting
- Metastatic breast cancer2 recruiting
- Neuroblastoma2 recruiting
- Triple-negative breast cancer2 recruiting
- Crohn's disease1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Hodgkin lymphoma1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lupus (SLE)1 recruiting
- Mantle cell lymphoma1 recruiting
- Migraine1 recruiting
- Multiple myeloma1 recruiting
- Multiple sclerosis1 recruiting
- Neurofibromatosis type 11 recruiting
- Psoriasis1 recruiting
- Psoriatic arthritis1 recruiting
- Rheumatoid arthritis1 recruiting
- Sjögren's disease1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Thyroid cancer1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Terminated
Completed
Completed
Terminated
A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies
Completed
Clinical Trial of Molecular Biomarkers in Women With Uterine Cervix Cancer
Terminated
Withdrawn
Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer
Terminated
Terminated
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
Completed
Completed
Completed
Terminated
Completed
Completed
Dose Escalation of Lapatinib With Paclitaxel in Ovarian Cancer
Completed
Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment
Completed
Completed
Completed
Accelerating Colorectal Cancer Screening Through Implementation Science in Appalachia
Terminated
Continued Treatment for Participants Enrolled in Studies of BXQ-350
Completed
Completed
Completed
Completed
Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia
Completed
Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer
Completed
Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors
Completed
Completed
Terminated
Completed
Completed
Withdrawn
Completed
Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Completed
Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma
Completed
Completed
Completed
Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma
Completed
Completed
Completed
MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer
Completed
Completed
Completed
Showing 50 of 82.
Registry name variants (6)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
University of Kentucky/Markey Cancer Center
Lexington, Kentucky 40536
322 trials
Markey Cancer Center
Lexington, Kentucky 40536
11 trials
University of Kentucky (UK) - Markey Cancer Center
Lexington, Kentucky 40536
5 trials
Markey Cancer Center - University of Kentucky
Lexington, Kentucky 40536
1 trial
University of Kentucky - Markey Cancer Center - 1112
Lexington, Kentucky 40536
1 trial
University of Kentucky, Markey Cancer Center (Site # 109)
Lexington, Kentucky 40536
1 trial
Contact: Principal Investigator
Institution data: ROR 01dhvva97 (CC0-1.0)Updated 15 Nov 2026